MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $691,135 | +9.5% | 11,764 | -18.8% | 0.01% | 0.0% |
Q3 2023 | $631,184 | +52.9% | 14,490 | +26.9% | 0.01% | +66.7% |
Q2 2023 | $412,677 | -5.0% | 11,422 | -2.2% | 0.00% | -25.0% |
Q1 2023 | $434,262 | -12.7% | 11,680 | +6.3% | 0.00% | -20.0% |
Q4 2022 | $497,685 | -32.6% | 10,984 | +4.0% | 0.01% | -37.5% |
Q3 2022 | $738,000 | +4.4% | 10,563 | +0.4% | 0.01% | +14.3% |
Q2 2022 | $707,000 | -17.7% | 10,526 | +0.7% | 0.01% | 0.0% |
Q1 2022 | $859,000 | -39.8% | 10,448 | +7.4% | 0.01% | -36.4% |
Q4 2021 | $1,427,000 | -17.8% | 9,726 | -0.8% | 0.01% | -21.4% |
Q3 2021 | $1,735,000 | +11.5% | 9,808 | +1.8% | 0.01% | +7.7% |
Q2 2021 | $1,556,000 | -11.3% | 9,635 | -6.0% | 0.01% | -13.3% |
Q1 2021 | $1,755,000 | -4.8% | 10,246 | +22.0% | 0.02% | -11.8% |
Q4 2020 | $1,844,000 | +29.8% | 8,396 | -1.9% | 0.02% | +21.4% |
Q3 2020 | $1,421,000 | +95.2% | 8,559 | +34.2% | 0.01% | +40.0% |
Q2 2020 | $728,000 | +57.2% | 6,379 | +6.0% | 0.01% | +25.0% |
Q1 2020 | $463,000 | – | 6,018 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $257,839,000 | 68.01% |
Boxer Capital, LLC | 2,000,000 | $164,440,000 | 8.45% |
Avoro Capital Advisors LLC | 5,325,000 | $437,822,000 | 7.99% |
M28 Capital Management LP | 82,900 | $6,816,000 | 6.27% |
Artal Group S.A. | 1,350,000 | $110,997,000 | 4.65% |
Nextech Invest Ltd. | 173,300 | $14,249,000 | 4.07% |
Perceptive Advisors | 2,380,710 | $195,742,000 | 3.92% |
Logos Global Management LP | 350,000 | $28,777,000 | 3.73% |
Camber Capital Management LP | 1,200,000 | $98,664,000 | 3.57% |
RTW INVESTMENTS, LP | 1,561,497 | $128,386,000 | 2.66% |